Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2020-038066
PubMed Identifier: 32998924
Publication URI: http://europepmc.org/abstract/MED/32998924
Type: Journal Article/Review
Parent Publication: BMJ Open
Issue: 9
ISSN: 2044-6055